Systematic reviews and meta-analyses on treatment of asthma: critical evaluation
- PMID: 10688558
- PMCID: PMC27295
- DOI: 10.1136/bmj.320.7234.537
Systematic reviews and meta-analyses on treatment of asthma: critical evaluation
Erratum in
- BMJ 2000 Apr 8;320(7240):984
- BMJ 2000 Jul 29;321(7256):275
Abstract
Objective: To evaluate the clinical, methodological, and reporting aspects of systematic reviews and meta-analyses on the treatment of asthma and to compare those published by the Cochrane Collaboration with those published in paper based journals.
Design: Analysis of studies identified from Medline, CINAHL, HealthSTAR, EMBASE, Cochrane Library, personal collections, and reference lists.
Studies: Articles describing a systematic review or a meta-analysis of the treatment of asthma that were published as a full report, in any language or format, in a peer reviewed journal or the Cochrane Library.
Main outcome measures: General characteristics of studies reviewed and methodological characteristics (sources of articles; language restrictions; format, design, and publication status of studies included; type of data synthesis; and methodological quality).
Results: 50 systematic reviews and meta-analyses were included. More than half were published in the past two years. Twelve reviews were published in the Cochrane Library and 38 were published in 22 peer reviewed journals. Forced expiratory volume in one second was the most frequently used outcome, but few reviews evaluated the effect of treatment on costs or patient preferences. Forty reviews were judged to have serious or extensive flaws. All six reviews associated with industry were in this group. Seven of the 10 most rigorous reviews were published in the Cochrane Library.
Conclusions: Most reviews published in peer reviewed journals or funded by industry have serious methodological flaws that limit their value to guide decisions. Cochrane reviews are more rigorous and better reported than those published in peer reviewed journals.
Comment in
-
The quality of systematic reviews. Review is biased.BMJ. 2000 Jul 29;321(7256):297. BMJ. 2000. PMID: 10979691 Free PMC article. No abstract available.
-
The quality of systematic reviews. High quality reporting of both randomised trials and systematic reviews should be priority.BMJ. 2000 Jul 29;321(7256):297; author reply 298-9. BMJ. 2000. PMID: 10979692 No abstract available.
-
The quality of systematic reviews. Criticism is unjustified.BMJ. 2000 Jul 29;321(7256):298; author reply 298-9. BMJ. 2000. PMID: 10979693 No abstract available.
-
The quality of systematic reviews. Cochrane Collaboration should ensure equitable participation in management and policy.BMJ. 2000 Jul 29;321(7256):298-9. BMJ. 2000. PMID: 10979694 No abstract available.
-
Meta-analysis of increased inhaled steroid or addition of salmeterol in asthma. Study should have been more thorough.BMJ. 2000 Oct 21;321(7267):1017-8. BMJ. 2000. PMID: 11039981 No abstract available.
-
Meta-analysis of increased inhaled steroid or addition of salmeterol in asthma. Researchers can learn from industry based reporting standards.BMJ. 2000 Oct 21;321(7267):1016-7; author reply 1017-8. BMJ. 2000. PMID: 11203208 Free PMC article. No abstract available.
References
-
- O'Byrne PM. Clinical comparisons of inhaler systems—what are the important aspects. J Aer Med. 1995;8:S39–S47. - PubMed
-
- Mulrow CD. Rationale for systematic reviews. In: Chalmers I, Altman DG, editors. Systematic reviews. London: BMJ Publishing; 1995. pp. 1–8.
-
- Lau J, Ioannidis JPA, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820–826. - PubMed
-
- Sacks HS, Berrier J, Reitman D, Pagano D, Chalmers T. Meta-analyses of randomized control trials: an update of the quality and methodology. In: Bailar JC III, Mosteller F, editors. Medical uses of statistics. Boston: New England Medical Journal Publications; 1992. pp. 427–442.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous